You are here: Industry Insights > COVID-19

News List

RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease prnasia
November 20, 2020
?RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for a Phase 2/3 study evaluating orally administered ...
Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim collaborate on first study to evaluate nintedanib in patients with fibrosing ILD following COVID-19 infection prnewswire
November 20, 2020
The Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim today announced the first patient has enrolled in a new clinical study to investigate the effect of nintedanib in adult patients having acute lung injury following COVID-19 infection.
Immunological memory after cured Sars-CoV-2 infection worldpharmanews
November 20, 2020
Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent immunological memory and thus can protect against a new infection.
Pharma supply chain still highly vulnerable to COVID-19 pandemic, says research europeanpharmaceuticalreview
November 20, 2020
Report reveals global pharma supply chain leaders are afraid of the vulnerabilities in the end-to-end supply chain as the COVID-19 pandemic continues.
CollPlant Announces Antiviral Agent Program for Potential Treatment of COVID-19 Patients americanpharmaceuticalreview
November 20, 2020
CollPlant announced its development program of an antiviral agent for potential treatment of COVID-19 patients. In-vitro early results of CollPlant's formulations showed significant inhibition of avian coronavirus infectivity.
Reimagining the next era of doctor engagement expresspharma
November 20, 2020
The COVID-19 pandemic has significantly altered the way doctors engage with their patients, and in turn, in the way that pharma companies approach doctors.
Olumniant (barcitinab) from Eli Lilly gets EUA from US FDA for COVID-19 treatment expresspharma
November 20, 2020
The US Food and Drug Administration (USFDA) issued an emergency use authorisation (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalised adults and pediatric ...
CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity prnasia
November 19, 2020
Gut microbiota plays an important role in regulating immunity against infections. People who suffer from imbalance in gut microbiota (dysbiosis) are more susceptible to viral infection and other complications.
Research Antibodies and Reagents Market Worth $6.32 billion by 2027 prnewswire
November 19, 2020
Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research
Eurofins Viracor Diagnostics Launches Combined Test For COVID-19, Influenza, And RSV As The Flu Season Approaches prnewswire
November 19, 2020
Eurofins Viracor, a leading infectious disease testing laboratory for more than 35 years, announces the launch of several combined tests which detect COVID-19, influenza A/B, and respiratory syncytial virus (RSV).